11. Five-year outcomes from a phase 3 METRIC study in patients with BRAF V600 E/K–mutant advanced or metastatic melanoma. (March 2019) Authors: Robert, Caroline; Flaherty, Keith; Nathan, Paul; Hersey, Peter; Garbe, Claus; Milhem, Mohammed; Demidov, Lev; Mohr, Peter; Hassel, Jessica C.; Rutkowski, Piotr; Dummer, Reinhard; Utikal, Jochen; Kiecker, Felix; Larkin, James; D'Amelio, Anthony; Mookerjee, Bijoyesh; Schadendorf, Dirk Journal: European journal of cancer Issue: Volume 109(2019) Page Start: 61 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
12. LGG-46. TRAMETINIB THERAPY IN PEDIATRIC PATIENTS WITH LOW-GRADE GLIOMAS (LGG) WITH BRAF GENE FUSION; A DISEASE-SPECIFIC COHORT IN THE FIRST PEDIATRIC TESTING OF TRAMETINIB. Issue 2 (22nd June 2018) Authors: Bouffet, Eric; Kieran, Mark; Hargrave, Darren; Roberts, Stephen; Aerts, Isabelle; Broniscer, Alberto; Geoerger, Birgit; Dasgupta, Kohinoor; Tseng, Lillian; Russo, Mark; Mookerjee, Bijoyesh; Moertel, Christopher Journal: Neuro-oncology Issue: Volume 20:Issue 2(2018)supplement 2 Page Start: i114 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
13. LGG-46. TRAMETINIB THERAPY IN PEDIATRIC PATIENTS WITH LOW-GRADE GLIOMAS (LGG) WITH BRAF GENE FUSION; A DISEASE-SPECIFIC COHORT IN THE FIRST PEDIATRIC TESTING OF TRAMETINIB. Issue 2 (22nd June 2018) Authors: Bouffet, Eric; Kieran, Mark; Hargrave, Darren; Roberts, Stephen; Aerts, Isabelle; Broniscer, Alberto; Geoerger, Birgit; Dasgupta, Kohinoor; Tseng, Lillian; Russo, Mark; Mookerjee, Bijoyesh; Moertel, Christopher Journal: Neuro-oncology Issue: Volume 20:Issue 2(2018)supplement 2 Page Start: i114 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
14. Long-term outcomes in patients with BRAF V600-mutant metastatic melanoma receiving dabrafenib monotherapy: Analysis from phase 2 and 3 clinical trials. (January 2020) Authors: Hauschild, Axel; Ascierto, Paolo A.; Schadendorf, Dirk; Grob, Jean Jacques; Ribas, Antoni; Kiecker, Felix; Dutriaux, Caroline; Demidov, Lev V.; Lebbé, Céleste; Rutkowski, Piotr; Blank, Christian U.; Gutzmer, Ralf; Millward, Michael; Kefford, Richard; Haas, Tomas; D'Amelio, Anthony; Gasal, Eduard;... Journal: European journal of cancer Issue: Volume 125(2020) Page Start: 114 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
15. Patient-reported outcomes in patients with resected, high-risk melanoma with BRAFV600E or BRAFV600K mutations treated with adjuvant dabrafenib plus trametinib (COMBI-AD): a randomised, placebo-controlled, phase 3 trial. Issue 5 (May 2019) Authors: Schadendorf, Dirk; Hauschild, Axel; Santinami, Mario; Atkinson, Victoria; Mandalà, Mario; Chiarion-Sileni, Vanna; Larkin, James; Nyakas, Marta; Dutriaux, Caroline; Haydon, Andrew; Robert, Caroline; Mortier, Laurent; Lesimple, Thierry; Plummer, Ruth; Schachter, Jacob; Dasgupta, Kohinoor; Manson, S... Journal: Lancet oncology Issue: Volume 20:Issue 5(2019) Page Start: 701 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
16. Pyrexia in dabrafenib-treated melanoma patients is not associated with common genetic variation or HLA polymorphisms. (April 2016) Authors: Kulkarni, Diptee; Song, Kijoung; Briley, Linda; King, Karen; Dabrowski, Christine; Mookerjee, Bijoyesh; Legos, Jeff; Spraggs, Colin Journal: Pharmacogenomics Issue: Volume 17:Number 5(2016) Page Start: 459 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
17. RARE-11. EFFICACY AND SAFETY OF DABRAFENIB + TRAMETINIB IN PATIENTS WITH RECURRENT/REFRACTORY BRAF V600E–MUTATED LOW-GRADE GLIOMA (LGG). (5th November 2018) Authors: Wen, Patrick; De Greve, Jacques; Mason, Warren; Hofheinz, Ralf-Dieter; Dietrich, Sascha; de Vos, Filip; van den Bent, Martin; Mookerjee, Bijoyesh; Boran, Aislyn; Burgess, Paul; Rangwala, Fatima; Gazzah, Anas Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 6 Page Start: vi238 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
18. Three-year pooled analysis of factors associated with clinical outcomes across dabrafenib and trametinib combination therapy phase 3 randomised trials. (September 2017) Authors: Schadendorf, Dirk; Long, Georgina V.; Stroiakovski, Daniil; Karaszewska, Boguslawa; Hauschild, Axel; Levchenko, Evgeny; Chiarion-Sileni, Vanna; Schachter, Jacob; Garbe, Claus; Dutriaux, Caroline; Gogas, Helen; Mandalà, Mario; Haanen, John B.A.G.; Lebbé, Céleste; Mackiewicz, Andrzej; Rutkowski, Pi... Journal: European journal of cancer Issue: Volume 82(2017) Page Start: 45 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗